Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02750943 · ClinicalTrials.gov registry record · NA

Potential of Stannous Fluoride Toothpaste to Reduce Gum Disease

A NA study of Gingivitis, sponsored by GlaxoSmithKline.

Completed
Registry status
NA
Development phase
253
Enrollment target
1
Study location

NCT02750943 is a NA study of Gingivitis that has completed, run by GlaxoSmithKline. The registered enrollment target is 253 participants, above the 227-participant average among 25 other Gingivitis trials with a reported enrollment target (11% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02750943, a NA study of Gingivitis, has completed, sponsored by GlaxoSmithKline.

COMPLETED
Registry status
NA
Development phase
253 participants
Enrollment target
1
Study location

Study Summary

This will be a single-center, 12 week, examiner-blind, randomized, stratified (gender and baseline mean whole mouth MGI score), two-treatment, parallel group, clinical study in healthy adult volunteers with moderate gingivitis. This study will evaluate the efficacy of a dentifrice containing 0.454% weight by weight (w/w) stannous fluoride to control gingivitis and gingival bleeding following 12 weeks twice daily brushing, compared to a negative control dentifrice.

Conditions Studied

Interventions

  • DRUG Stannous Fluoride
  • DRUG Sodium Monofluorophosphate

Study Locations (1)

Nevada

  • GSK Investigational Site - Las Vegas

Trial Details

FieldValue
Enrollment Target 253 participants
Start Date 2015-11-01
Est. Completion 2016-03-04
Phase NA

Sponsor

GlaxoSmithKline

1,345 total trials

What the Registry Record Tells You About NCT02750943

The ClinicalTrials.gov registry entry for NCT02750943 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 253 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 227-participant average among 25 other Gingivitis trials with a reported enrollment target (11% higher). The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Gingivitis appearing as the primary indexed condition, and to 2 interventions - of which Stannous Fluoride is the first listed.

NCT02750943 reports 1 study location spanning 1 distinct geographic area - top geographies include Nevada.

Frequently Asked Questions

What is clinical trial NCT02750943 about?

NCT02750943 is a clinical study titled "Potential of Stannous Fluoride Toothpaste to Reduce Gum Disease". This will be a single-center, 12 week, examiner-blind, randomized, stratified (gender and baseline mean whole mouth MGI score), two-treatment, parallel group, clinical study in healthy adult volunteers with moderate gingivitis. This study will evaluate the efficacy of a dentifrice containing 0.454% ...

What is the current status of trial NCT02750943?

This trial is currently completed. It is a NA study. The enrollment target is 253 participants. The study started on 2015-11-01. Estimated completion is 2016-03-04.

What conditions does trial NCT02750943 study?

This clinical trial studies the following conditions: Gingivitis.

What interventions are being tested in trial NCT02750943?

The interventions under investigation include: Stannous Fluoride (DRUG), Sodium Monofluorophosphate (DRUG).

Who is sponsoring clinical trial NCT02750943?

This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02750943 being conducted?

This trial has 1 study location across Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gingivitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.